Abraham Ceesay - 02 Feb 2026 Form 4 Insider Report for Rapport Therapeutics, Inc. (RAPP)

Role: Chief Executive Officer, Director
Signature: /s/ Troy Ignelzi, Attorney-in-Fact
Issuer symbol: RAPP
Transactions as of: 02 Feb 2026
Net transactions value: $0
Form type: 4
Filing time: 04 Feb 2026, 16:14:58 UTC
Previous filing: 22 Jan 2026
Next filing: 19 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Ceesay Abraham	Chief Executive Officer, Director	RAPPORT THERAPEUTICS, INC., 99 HIGH STREET, SUITE 2100, BOSTON	/s/ Troy Ignelzi, Attorney-in-Fact	04 Feb 2026	0001722140

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RAPP	Stock Option (Right to Buy)	Award	$0	+428,000		$0.000000	428,000	02 Feb 2026	Common Stock	428,000	$27.75	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following January 1, 2026, subject to the Reporting Person's continued service on each such vesting date.